Innate PharmaBeyond's analysis on Innate Pharma2026-08-10 — Sobi and Innate Pharma partner to accelerate lacutamab development in T-cell lymphoma2026-08-10 — Sobi and Innate Pharma partner to advance lacutamab in T-cell lymphoma, expanding oncology collaborationRecent news mentioning Innate Pharma2026-09-23 — Innate Pharma (IPHA) Closes Sobi Deal. Can the New Funding Keep Drug Trials on Track?2026-09-18 — Innate Pharma (IPHA) Q2 2026 Earnings Call Transcript2026-09-17 — Innate Pharma Q2 Earnings Call HighlightsBrowse the full archive →